1841429982 SOL SURGERY

Medical Specialty Clinic/Center

Active

Basic Information

Organization Name
SOL SURGERY
Enumeration Date
July 10, 2009
Last Update
February 5, 2024
Authorized Official
DR. SABATO ORTIZ M.D
CEO
Phone: (787) 360-4723

Practice Location

Address
AVE. SAN CRISTOBAL, SAN CRISTOBAL MEDICAL TOWER
SUITE 304
COTO LAUREL, PR 007802861
Phone
(787) 360-4723

Mailing Address

Address
AVE. SAN CRISTOBAL, SAN CRISTOBAL MEDICAL TOWER
SUITE 304
COTO LAUREL, PR 007802861
Phone
(787) 360-4723

Specialties & Taxonomies

Specialty Code Classification License State Primary
Medical Specialty Clinic/Center
Medical Specialty
261QM2500X Clinic/Center 17489 PR Primary

Frequently Asked Questions

What is SOL SURGERY's NPI number?
SOL SURGERY's NPI number is 1841429982.
Which doctor has NPI number 1841429982?
The doctor with NPI number 1841429982 is SOL SURGERY.
What is SOL SURGERY's practice address?
SOL SURGERY's practice address is AVE. SAN CRISTOBAL, SAN CRISTOBAL MEDICAL TOWER, SUITE 304, COTO LAUREL, PR, 007802861.
Which doctor practices at AVE. SAN CRISTOBAL, SAN CRISTOBAL MEDICAL TOWER, SUITE 304, COTO LAUREL, PR, 007802861?
SOL SURGERY practices at AVE. SAN CRISTOBAL, SAN CRISTOBAL MEDICAL TOWER, SUITE 304, COTO LAUREL, PR, 007802861.
What is SOL SURGERY's phone number?
SOL SURGERY's phone number is (787) 360-4723.
Who is (787) 360-4723?
(787) 360-4723 is the phone number for SOL SURGERY.
What is SOL SURGERY's specialty?
SOL SURGERY's specialty is Medical Specialty Clinic/Center.
What type of doctor is SOL SURGERY?
SOL SURGERY is a Medical Specialty Clinic/Center.
Is SOL SURGERY a Medical Specialty?
Yes, SOL SURGERY is a Medical Specialty.
Is SOL SURGERY still practicing?
Yes, SOL SURGERY is currently practicing.
Is SOL SURGERY accepting new patients?
SOL SURGERY may be accepting new patients. Please call their office at (787) 360-4723 to inquire about availability.
Is NPI 1841429982 still active?
Yes, NPI 1841429982 is currently active.
Where does SOL SURGERY practice?
SOL SURGERY practices in COTO LAUREL, PR.